Phase 3 monotherapy available Feature Expected GI burden Cagrilintide + Retatrutide Very high CagriSema (Cag + Sema) High Retatrutide Alone High Feature Dysesthesia risk Cagrilintide + Retatrutide Yes (retatrutide component) CagriSema (Cag + Sema) No Retatrutide Alone Yes Feature Injections per week Cagrilintide + Retatrutide 2 (separate) or 1 (pre-blend) CagriSema (Cag + Sema) 1 or 2 Retatrutide Alone 1 Feature Regulatory status Cagrilintide + Retatrutide Neither approved
This blog explores the similarities and differences between Semaglutide and these newer peptides, focusing on mechanisms of action, research applications, and metabolic relevance
Common schedules include weekly for 46 weeks, then monthly maintenance, or bi-weekly depending on baseline B12 status and clinical goals
\u201cFat Transfer\u201d is the process of liposuctioning, or removing, fat from the body and then reinjecting it to other parts of the body
Chiropractic adjustments/mobilization to normalize joint and soft-tissue mechanics, reducing nociceptive drive and improving movement quality
Brown and beige fat: development, function and therapeutic potential
